"set_id","name","GENE.SET","MEAN.ABS.T0","PADOG0","P.MEAN.ABS.T","PVAL"
"WP2023","Cell Differentiation - Index expanded","WP2023",4.65,3.97,0.002,1e-05
"WP2029","Cell Differentiation - Index","WP2029",4.49,3.78,1e-05,1e-05
"WP1991","SRF and miRs in Smooth Muscle Differentiation and Proliferation","WP1991",5.77,4.98,0.002,0.001
"WP2355","Corticotropin-releasing hormone signaling pathway","WP2355",2.65,0.539,0.016,0.005
"WP2361","Gastric Cancer Network 1","WP2361",5.83,5.94,0.02,0.012
"WP4300","Extracellular vesicles in the crosstalk of cardiac cells","WP4300",2.98,1.79,0.025,0.013
"WP554","ACE Inhibitor Pathway","WP554",3.32,3.11,0.015,0.017
"WP1602","Nicotine Activity on Dopaminergic Neurons","WP1602",2.95,2.84,0.025,0.022
"WP289","Myometrial Relaxation and Contraction Pathways","WP289",4.39,3.34,0.027,0.023
"WP466","DNA Replication","WP466",7.06,6.95,0.029,0.026
"WP3996","Ethanol effects on histone modifications","WP3996",2.9,2.75,0.028,0.029
"WP2197","Endothelin Pathways","WP2197",2.33,1.79,0.057,0.031
"WP3944","Serotonin and anxiety-related events","WP3944",3.63,2.35,0.024,0.032
"WP4222","Phosphodiesterases in neuronal function","WP4222",3.35,3.29,0.036,0.032
"WP2516","ATM Signaling Pathway","WP2516",3.11,1.92,0.066,0.034
"WP35","G Protein Signaling Pathways","WP35",3.9,3.17,0.058,0.034
"WP4337","ncRNAs involved in STAT3 signaling in hepatocellular carcinoma","WP4337",3.19,1.59,0.045,0.036
"WP4016","DNA IR-damage and cellular response via ATR","WP4016",4.23,3.94,0.047,0.042
"WP179","Cell Cycle","WP179",4.97,4.06,0.057,0.044
"WP2276","Glial Cell Differentiation","WP2276",2.33,2.36,0.033,0.044
"WP4589","Major receptors targeted by epinephrine and norepinephrine","WP4589",2.52,2.36,0.043,0.044
"WP4481","Resistin as a regulator of inflammation","WP4481",0.837,-1.09,0.215,0.045
"WP170","Nuclear Receptors","WP170",2.26,2.09,0.052,0.055
"WP45","G1 to S cell cycle control","WP45",4.7,3.8,0.076,0.055
"WP2032","Human Thyroid Stimulating Hormone (TSH) signaling pathway","WP2032",1.21,-0.856,0.161,0.056
"WP4545","Oxysterols derived from cholesterol","WP4545",2.36,2.34,0.048,0.056
"WP247","Small Ligand GPCRs","WP247",2.85,2.86,0.046,0.058
"WP3972","PDGFR-beta pathway","WP3972",0.799,-1.47,0.264,0.059
"WP3959","DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM","WP3959",2.85,2.02,0.076,0.06
"WP531","DNA Mismatch Repair","WP531",3.42,3.33,0.06,0.06
"WP236","Adipogenesis","WP236",3.23,2.04,0.071,0.062
"WP2431","Spinal Cord Injury","WP2431",2.99,1.54,0.077,0.063
"WP2446","Retinoblastoma Gene in Cancer","WP2446",6.49,5.76,0.077,0.064
"WP410","Exercise-induced Circadian Regulation","WP410",2.06,2.17,0.043,0.066
"WP734","Serotonin Receptor 4/6/7 and NR3C Signaling","WP734",0.96,-0.0811,0.109,0.067
"WP1530","miRNA Regulation of DNA Damage Response","WP1530",2.94,1.56,0.101,0.069
"WP4535","Envelope proteins and their potential roles in EDMD physiopathology","WP4535",0.883,-0.0123,0.165,0.069
"WP706","Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways","WP706",2.09,1.29,0.073,0.069
"WP707","DNA Damage Response","WP707",2.81,1.42,0.105,0.077
"WP516","Hypertrophy Model","WP516",2.58,2.33,0.067,0.079
"WP4760","PKC-gamma calcium signaling pathway in ataxia","WP4760",2.6,2.31,0.071,0.083
"WP206","Fatty Acid Omega Oxidation","WP206",2.59,2.63,0.082,0.086
"WP2332","Interleukin-11 Signaling Pathway","WP2332",-0.0761,-1.89,0.431,0.086
"WP545","Complement Activation","WP545",3.38,3.38,0.086,0.087
"WP1528","Physiological and Pathological Hypertrophy  of the Heart","WP1528",1.68,0.0921,0.12,0.088
"WP2363","Gastric Cancer Network 2","WP2363",2.23,2.1,0.105,0.088
"WP4149","White fat cell differentiation","WP4149",2.24,1.72,0.082,0.089
"WP383","Striated Muscle Contraction Pathway","WP383",3.63,3.71,0.09,0.092
"WP2806","Human Complement System","WP2806",3.42,3.25,0.088,0.097
"WP2815","Mammary gland development pathway - Involution (Stage 4 of 4)","WP2815",1.85,0.685,0.138,0.097
"WP3299","let-7 inhibition of ES cell reprogramming","WP3299",2.08,1.36,0.088,0.098
"WP474","Endochondral Ossification","WP474",2.41,1.81,0.109,0.099
"WP558","Complement and Coagulation Cascades","WP558",3.35,3.36,0.091,0.1
"WP536","Calcium Regulation in the Cardiac Cell","WP536",3.57,3.14,0.112,0.101
"WP2855","Dopaminergic Neurogenesis","WP2855",2.1,1.73,0.118,0.102
"WP2406","Cardiac Progenitor Differentiation","WP2406",2.36,1.51,0.08,0.104
"WP4752","Base Excision Repair","WP4752",1.94,1.95,0.082,0.104
"WP2848","Differentiation Pathway","WP2848",2.55,1.58,0.088,0.107
"WP4240","Regulation of sister chromatid separation at the metaphase-anaphase transition","WP4240",2.93,3.03,0.101,0.107
"WP3893","Development and heterogeneity of the ILC family","WP3893",2.68,2.14,0.069,0.11
"WP2849","Hematopoietic Stem Cell Differentiation","WP2849",2.77,1.98,0.085,0.12
"WP3594","Circadian rhythm related genes","WP3594",1.98,1.21,0.101,0.121
"WP1971","Integrated Cancer Pathway","WP1971",1.86,0.186,0.172,0.123
"WP3591","Sleep regulation","WP3591",2.46,1.3,0.043,0.123
"WP3599","Transcription factor regulation in adipogenesis","WP3599",1.61,0.435,0.103,0.123
"WP34","Ovarian Infertility Genes","WP34",1.46,1.09,0.114,0.126
"WP497","Urea cycle and metabolism of amino groups","WP497",1.96,2,0.094,0.136
"WP727","Monoamine Transport","WP727",1.65,1.24,0.134,0.137
"WP3611","Photodynamic therapy-induced AP-1 survival signaling.","WP3611",1.88,-0.251,0.149,0.138
"WP1423","Ganglio Sphingolipid Metabolism","WP1423",1.56,1.65,0.103,0.148
"WP241","One Carbon Metabolism","WP241",1.69,1.56,0.113,0.149
"WP3947","Serotonin and anxiety","WP3947",2.21,1.06,0.078,0.15
"WP4321","Thermogenesis","WP4321",0.636,-0.11,0.246,0.16
"WP1544","MicroRNAs in cardiomyocyte hypertrophy","WP1544",-0.0823,-1.86,0.536,0.161
"WP1984","Integrated Breast Cancer Pathway","WP1984",0.94,-0.623,0.271,0.161
"WP4560","MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement","WP4560",1.37,0.572,0.201,0.161
"WP2038","Regulation of Microtubule Cytoskeleton","WP2038",1.03,0.327,0.214,0.165
"WP3888","VEGFA-VEGFR2 Signaling Pathway","WP3888",0.532,-0.684,0.256,0.166
"WP3995","Prion disease pathway","WP3995",1.14,-0.0857,0.164,0.166
"WP465","Tryptophan metabolism","WP465",1.73,1.76,0.138,0.168
"WP1545","miRNAs involved in DNA damage response","WP1545",0.93,-0.243,0.274,0.169
"WP1434","Osteopontin Signaling","WP1434",0.816,-0.536,0.267,0.173
"WP560","TGF-beta Receptor Signaling","WP560",1.01,-0.319,0.231,0.175
"WP2011","SREBF and miR33 in cholesterol and lipid homeostasis","WP2011",1.31,0.766,0.153,0.178
"WP2374","Oncostatin M Signaling Pathway","WP2374",0.0586,-2.25,0.478,0.184
"WP4583","Biomarkers for urea cycle disorders","WP4583",1.47,1.48,0.139,0.184
"WP1601","Fluoropyrimidine Activity","WP1601",1.68,1.64,0.177,0.186
"WP1992","Genes targeted by miRNAs in adipocytes","WP1992",1.64,1.42,0.132,0.187
"WP2879","Farnesoid X Receptor  Pathway","WP2879",1.45,1.23,0.162,0.189
"WP4658","Small cell lung cancer","WP4658",0.928,-1.04,0.338,0.19
"WP1541","Energy Metabolism","WP1541",0.838,-0.0844,0.184,0.192
"WP4584","Biomarkers for pyrimidine metabolism disorders","WP4584",1.54,1.52,0.151,0.192
"WP3679","Cell-type Dependent Selectivity of CCK2R Signaling","WP3679",1.83,1.63,0.153,0.193
"WP176","Folate Metabolism","WP176",1.85,0.997,0.171,0.197
"WP186","Homologous recombination","WP186",1.35,1.17,0.158,0.201
"WP3876","BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation","WP3876",1.04,0.69,0.213,0.203
"WP4224","Purine metabolism and related disorders","WP4224",1.21,1.27,0.152,0.203
"WP3958","GPR40 Pathway","WP3958",1.29,1.09,0.166,0.205
"WP2874","Liver X Receptor Pathway","WP2874",1.23,0.936,0.2,0.206
"WP384","Apoptosis Modulation by HSP70","WP384",1.19,0.15,0.215,0.207
"WP2525","Trans-sulfuration and one carbon metabolism","WP2525",1.44,1.29,0.173,0.212
"WP3584","MECP2 and Associated Rett Syndrome","WP3584",0.977,0.417,0.178,0.212
"WP4698","Vitamin D-sensitive calcium signaling in depression","WP4698",1.38,0.87,0.154,0.218
"WP2064","Neural Crest Differentiation","WP2064",1.36,0.635,0.217,0.221
"WP2059","Alzheimers Disease","WP2059",1.1,0.32,0.239,0.222
"WP3303","RAC1/PAK1/p38/MMP2 Pathway","WP3303",-0.73,-2.6,0.718,0.226
"WP2338","miRNA Biogenesis","WP2338",1,1.06,0.174,0.228
"WP4186","Somatroph axis (GH) and its relationship to dietary restriction and aging","WP4186",0.645,-0.296,0.282,0.23
"WP732","Serotonin Receptor 2 and ELK-SRF/GATA4 signaling","WP732",0.104,-1.06,0.423,0.236
"WP4304","Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS","WP4304",1.35,1.11,0.22,0.237
"WP138","Androgen receptor signaling pathway","WP138",0.225,-0.951,0.367,0.238
"WP3287","Overview of nanoparticle effects","WP3287",1.39,-0.267,0.125,0.246
"WP4482","Vitamin D in inflammatory diseases","WP4482",0.595,-1,0.302,0.247
"WP4493","Cells and Molecules involved in local acute inflammatory response ","WP4493",1.85,1.08,0.18,0.247
"WP4756","Renin Angiotensin Aldosterone System (RAAS)","WP4756",1.07,0.782,0.23,0.25
"WP58","Monoamine GPCRs","WP58",1.11,1.11,0.194,0.255
"WP382","MAPK Signaling Pathway","WP382",0.104,-1.64,0.502,0.256
"WP2881","Estrogen Receptor Pathway","WP2881",0.908,0.348,0.275,0.257
"WP4719","Eicosanoid metabolism via Cyclo Oxygenases (COX)","WP4719",1.41,1.34,0.212,0.258
"WP2840","Hair Follicle Development: Cytodifferentiation (Part 3 of 3)","WP2840",1.56,0.723,0.235,0.259
"WP4259","Disorders of Folate Metabolism and Transport","WP4259",1.2,1.05,0.21,0.261
"WP2814","Mammary gland development pathway - Puberty (Stage 2 of 4)","WP2814",1.13,0.548,0.283,0.266
"WP2485","NAD Biosynthesis II (from tryptophan)","WP2485",1.03,1.06,0.222,0.271
"WP322","Osteoblast Signaling","WP322",1.02,0.73,0.248,0.272
"WP98","Prostaglandin Synthesis and Regulation","WP98",1.63,1.53,0.23,0.273
"WP4172","PI3K-Akt Signaling Pathway","WP4172",0.551,-1.47,0.454,0.277
"WP3298","Melatonin metabolism and effects","WP3298",1.23,0.378,0.238,0.28
"WP4022","Pyrimidine metabolism","WP4022",1.02,1.13,0.228,0.284
"WP24","Peptide GPCRs","WP24",1.66,1.64,0.234,0.288
"WP3875","ATR Signaling","WP3875",0.757,0.678,0.217,0.293
"WP428","Wnt Signaling","WP428",0.825,-0.254,0.316,0.293
"WP53","ID signaling pathway","WP53",1.07,0.524,0.238,0.293
"WP2113","Type III interferon signaling","WP2113",0.793,0.14,0.277,0.294
"WP3892","Development of pulmonary dendritic cells and macrophage subsets","WP3892",1.1,0.866,0.275,0.297
"WP3414","Initiation of transcription and translation elongation at the HIV-1 LTR","WP3414",0.348,-0.354,0.259,0.304
"WP3929","Chemokine signaling pathway","WP3929",-0.0776,-1.73,0.541,0.307
"WP4298","Viral Acute Myocarditis","WP4298",0.599,-1.07,0.349,0.307
"WP3670","Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway","WP3670",0.583,0.296,0.257,0.311
"WP4571","Urea cycle and related diseases","WP4571",0.895,0.925,0.253,0.314
"WP3624","Lung fibrosis","WP3624",1.41,0.593,0.242,0.32
"WP4754","IL-18 signaling pathway","WP4754",0.872,-0.42,0.329,0.32
"WP306","Focal Adhesion","WP306",0.454,-1.16,0.441,0.321
"WP4290","Metabolic reprogramming in colon cancer","WP4290",0.805,0.741,0.272,0.328
"WP4666","Hepatitis B infection","WP4666",-0.596,-3.65,0.623,0.328
"WP2036","TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway","WP2036",-0.0759,-2.1,0.492,0.335
"WP3640","Imatinib and Chronic Myeloid Leukemia","WP3640",0.852,0.308,0.285,0.338
"WP3658","Wnt/beta-catenin Signaling Pathway in Leukemia","WP3658",0.272,-0.379,0.401,0.339
"WP3668","Hypothesized Pathways in Pathogenesis of Cardiovascular Disease","WP3668",0.334,-0.252,0.431,0.341
"WP712","Estrogen signaling pathway","WP712",-0.304,-2.52,0.481,0.341
"WP2371","Parkinsons Disease Pathway","WP2371",0.532,-0.00984,0.299,0.343
"WP2636","Common Pathways Underlying Drug Addiction","WP2636",0.0503,-0.992,0.411,0.343
"WP272","Blood Clotting Cascade","WP272",1.08,1.07,0.286,0.347
"WP3595","mir-124 predicted interactions with cell cycle and differentiation ","WP3595",0.271,0.301,0.297,0.347
"WP4008","NO/cGMP/PKG mediated Neuroprotection","WP4008",0.535,-0.545,0.33,0.349
"WP4204","Tumor suppressor activity of SMARCB1","WP4204",0.728,0.551,0.293,0.351
"WP3646","Hepatitis C and Hepatocellular Carcinoma","WP3646",-0.0122,-1.99,0.525,0.355
"WP1455","Serotonin Transporter Activity","WP1455",0.631,0.451,0.33,0.36
"WP4191","Caloric restriction and aging","WP4191",0.297,-0.316,0.436,0.36
"WP364","IL-6 signaling pathway","WP364",-0.45,-2.26,0.616,0.361
"WP167","Eicosanoid Synthesis","WP167",0.955,0.912,0.287,0.362
"WP2895","Differentiation of white and brown adipocyte   ","WP2895",0.77,0.605,0.311,0.365
"WP3943","Robo4 and VEGF Signaling Pathways Crosstalk","WP3943",-0.127,-0.304,0.51,0.365
"WP4288","MTHFR deficiency","WP4288",0.69,0.334,0.306,0.367
"WP26","Signal Transduction of S1P Receptor","WP26",0.244,-0.254,0.438,0.368
"WP395","IL-4 Signaling Pathway","WP395",-0.389,-2.37,0.609,0.368
"WP3580","Methionine De Novo and Salvage Pathway","WP3580",0.7,0.743,0.287,0.369
"WP3849","MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ","WP3849",-0.471,-1.54,0.623,0.369
"WP2817","Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)","WP2817",0.349,-0.221,0.408,0.37
"WP4211","Transcriptional cascade regulating adipogenesis","WP4211",0.709,0.6,0.325,0.37
"WP2878","PPAR Alpha Pathway","WP2878",0.462,-0.15,0.343,0.371
"WP4629","Computational Model of Aerobic Glycolysis","WP4629",0.431,0.352,0.32,0.373
"WP4538","Regulatory circuits of the STAT3 signaling pathway","WP4538",0.548,-0.488,0.421,0.374
"WP2858","Ectoderm Differentiation","WP2858",0.883,0.741,0.311,0.377
"WP2267","Synaptic Vesicle Pathway","WP2267",0.64,0.758,0.302,0.378
"WP4753","Nucleotide Excision Repair","WP4753",0.473,0.458,0.288,0.378
"WP262","EBV LMP1 signaling","WP262",-0.316,-1.39,0.543,0.379
"WP1591","Heart Development","WP1591",0.52,0.0985,0.399,0.38
"WP1403","AMP-activated Protein Kinase (AMPK) Signaling","WP1403",-0.414,-1.39,0.55,0.384
"WP107","Translation Factors","WP107",0.211,0.286,0.296,0.386
"WP2795","Cardiac Hypertrophic Response","WP2795",-0.518,-2.11,0.699,0.386
"WP2369","Histone Modifications","WP2369",0.567,0.685,0.288,0.387
"WP3878","ATM Signaling Network in Development and Disease ","WP3878",0.265,-0.229,0.339,0.388
"WP2034","Leptin signaling pathway","WP2034",-1.27,-3.54,0.798,0.389
"WP127","IL-5 Signaling Pathway","WP127",-0.414,-2.82,0.603,0.391
"WP117","GPCRs, Other","WP117",1.03,1.06,0.313,0.392
"WP4225","Pyrimidine metabolism and related diseases","WP4225",0.806,0.755,0.312,0.393
"WP2118","Arrhythmogenic Right Ventricular Cardiomyopathy","WP2118",0.689,0.523,0.391,0.394
"WP4147","PTF1A related regulatory pathway","WP4147",0.0857,-0.0368,0.438,0.395
"WP3963","Mevalonate pathway","WP3963",0.406,0.427,0.334,0.399
"WP4480","Role of Altered Glycolysation of MUC1 in Tumour Microenvironment","WP4480",0.335,-1.48,0.381,0.4
"WP524","G13 Signaling Pathway","WP524",-0.124,-0.753,0.475,0.4
"WP2507","Nanomaterial induced apoptosis","WP2507",0.469,-0.619,0.296,0.402
"WP1742","TP53 Network","WP1742",0.708,-0.607,0.355,0.404
"WP4320","The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome","WP4320",0.241,-0.0357,0.366,0.405
"WP3527","Preimplantation Embryo","WP3527",0.798,0.657,0.31,0.41
"WP411","mRNA Processing","WP411",-0.581,-0.271,0.321,0.412
"WP366","TGF-beta Signaling Pathway","WP366",-0.555,-1.95,0.576,0.413
"WP3941","Oxidative Damage","WP3941",0.391,-0.79,0.422,0.416
"WP4539","Synaptic signaling pathways associated with autism spectrum disorder","WP4539",-0.491,-2.09,0.63,0.42
"WP4685","Melanoma","WP4685",-0.892,-2.88,0.788,0.423
"WP254","Apoptosis","WP254",0.085,-1.38,0.51,0.424
"WP4673","Genes involved in male infertility","WP4673",0.506,0.184,0.361,0.43
"WP3998","Prader-Willi and Angelman Syndrome","WP3998",0.324,-0.0975,0.438,0.431
"WP4269","Ethanol metabolism resulting in production of ROS by CYP2E1","WP4269",-0.127,-0.576,0.531,0.432
"WP2380","Brain-Derived Neurotrophic Factor (BDNF) signaling pathway","WP2380",-0.697,-2.86,0.648,0.436
"WP3657","Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex","WP3657",0.368,-0.356,0.336,0.438
"WP4767","FGFR3 signalling in chondrocyte proliferation and terminal differentiation","WP4767",-0.0514,-1.01,0.537,0.438
"WP51","Regulation of Actin Cytoskeleton","WP51",-0.342,-1.24,0.577,0.439
"WP136","Phase I biotransformations, non P450","WP136",0.634,0.66,0.362,0.444
"WP3301","MFAP5-mediated ovarian cancer cell motility and invasiveness","WP3301",-0.0361,-0.849,0.506,0.446
"WP3613","Photodynamic therapy-induced unfolded protein response","WP3613",0.459,0.421,0.355,0.448
"WP4462","Platelet-mediated interactions with vascular and circulating cells","WP4462",0.42,-0.0615,0.438,0.452
"WP4507","Molybdenum cofactor (Moco) biosynthesis","WP4507",0.286,0.33,0.356,0.453
"WP3585","Cytosine methylation","WP3585",0.349,0.325,0.35,0.454
"WP3932","Focal Adhesion-PI3K-Akt-mTOR-signaling pathway","WP3932",-0.326,-1.77,0.616,0.454
"WP1946","Cori Cycle","WP1946",0.102,-0.0555,0.394,0.455
"WP231","TNF alpha Signaling Pathway","WP231",-0.619,-2.24,0.639,0.456
"WP3672","LncRNA-mediated mechanisms of therapeutic resistance","WP3672",0.135,-0.288,0.506,0.456
"WP28","Selenium Metabolism and Selenoproteins","WP28",0.625,-0.229,0.315,0.457
"WP2911","miRNA targets in ECM and membrane receptors","WP2911",0.247,0.176,0.43,0.461
"WP2447","Amyotrophic lateral sclerosis (ALS)","WP2447",-0.0765,-1.19,0.464,0.462
"WP2865","IL1 and megakaryocytes in obesity","WP2865",0.45,-0.0274,0.47,0.463
"WP4341","Non-genomic actions of 1,25 dihydroxyvitamin D3","WP4341",0.301,-1.59,0.472,0.464
"WP4553","FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma","WP4553",0.165,-0.0706,0.449,0.464
"WP4286","Genotoxicity pathway","WP4286",0.651,0.544,0.39,0.465
"WP4566","Translation inhibitors in chronically activated PDGFRA cells","WP4566",-0.935,-2.53,0.756,0.467
"WP3935","Leptin Insulin Overlap","WP3935",0.027,-0.643,0.532,0.468
"WP698","Glucuronidation","WP698",0.452,0.498,0.382,0.469
"WP3407","FTO Obesity Variant Mechanism","WP3407",0.621,0.509,0.362,0.472
"WP530","Cytokines and Inflammatory Response","WP530",0.695,-0.124,0.392,0.472
"WP3529","Zinc homeostasis","WP3529",0.347,0.443,0.395,0.473
"WP4357","NRF2-ARE regulation","WP4357",0.0647,-0.688,0.5,0.473
"WP15","Selenium Micronutrient Network","WP15",0.667,-0.104,0.384,0.478
"WP2037","Prolactin Signaling Pathway","WP2037",-0.791,-3.34,0.748,0.481
"WP4540","Pathways Regulating Hippo Signaling","WP4540",-0.178,-1.1,0.517,0.482
"WP3940","One carbon metabolism and related pathways","WP3940",0.484,0.339,0.393,0.486
"WP1533","Vitamin B12 Metabolism","WP1533",0.574,-0.398,0.43,0.487
"WP2007","Iron metabolism in placenta","WP2007",0.307,0.365,0.403,0.492
"WP2870","Extracellular vesicle-mediated signaling in recipient cells","WP2870",-0.651,-1.53,0.689,0.492
"WP4657","22q11.2 Deletion Syndrome","WP4657",0.457,0.374,0.42,0.494
"WP2112","IL17 signaling pathway","WP2112",-0.494,-1.87,0.6,0.496
"WP4236","Disorders of the Krebs cycle","WP4236",-0.00205,0.0313,0.402,0.497
"WP4495","IL-10 Anti-inflammatory Signaling Pathway ","WP4495",0.621,-0.679,0.328,0.5
"WP2813","Mammary gland development pathway - Embryonic development (Stage 1 of 4)","WP2813",-0.0789,-0.737,0.553,0.502
"WP585","Interferon type I signaling pathways","WP585",-0.356,-1.75,0.597,0.505
"WP23","B Cell Receptor Signaling Pathway","WP23",-0.974,-2.76,0.732,0.506
"WP2586","Aryl Hydrocarbon Receptor Netpath","WP2586",-0.351,-1.67,0.597,0.51
"WP3971","Role of Osx and miRNAs in tooth development","WP3971",0.0582,-0.153,0.524,0.514
"WP314","Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation","WP314",-0.0226,-0.943,0.531,0.519
"WP3617","Photodynamic therapy-induced NF-kB survival signaling","WP3617",0.0179,-1.15,0.529,0.52
"WP1772","Apoptosis Modulation and Signaling","WP1772",0.15,-1.22,0.493,0.521
"WP4216","Chromosomal and microsatellite instability in colorectal cancer ","WP4216",-0.574,-2.77,0.697,0.521
"WP4249","Hedgehog Signaling Pathway","WP4249",0.119,-0.206,0.455,0.522
"WP183","Proteasome Degradation","WP183",-0.664,-0.485,0.456,0.523
"WP437","EGF/EGFR Signaling Pathway","WP437",-0.795,-2.62,0.637,0.525
"WP3930","EDA Signalling in Hair Follicle Development","WP3930",0.281,0.259,0.446,0.526
"WP4541","Hippo-Merlin Signaling Dysregulation","WP4541",-0.199,-0.887,0.578,0.526
"WP1539","Angiogenesis","WP1539",-0.525,-1.29,0.653,0.529
"WP4558","Overview of interferons-mediated signaling pathway","WP4558",-0.177,-1.16,0.516,0.529
"WP4312","Rett syndrome causing genes","WP4312",0.164,0.00715,0.431,0.53
"WP4223","Ras Signaling","WP4223",-1.04,-2.61,0.759,0.532
"WP4659","Gastrin Signaling Pathway","WP4659",-1.4,-3.97,0.846,0.532
"WP4518","Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases","WP4518",0.105,0.104,0.455,0.533
"WP4262","Breast cancer pathway","WP4262",-0.685,-2.73,0.758,0.541
"WP4331","Neovascularisation processes","WP4331",-0.467,-1.36,0.639,0.542
"WP197","Cholesterol Biosynthesis Pathway","WP197",-0.352,-0.332,0.471,0.543
"WP3630","NAD metabolism, sirtuins and aging","WP3630",0.227,-0.463,0.446,0.545
"WP129","Matrix Metalloproteinases","WP129",0.376,0.364,0.475,0.548
"WP3863","T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection","WP3863",-1.01,-2.6,0.662,0.55
"WP4336","ncRNAs involved in Wnt signaling in hepatocellular carcinoma","WP4336",0.0538,-0.685,0.526,0.556
"WP2203","Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway","WP2203",-0.236,-2.45,0.601,0.557
"WP2261","Signaling Pathways in Glioblastoma","WP2261",-1.07,-3.06,0.883,0.558
"WP4746","Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism","WP4746",-0.794,-1.94,0.766,0.564
"WP4533","Transcription co-factors SKI and SKIL protein partners","WP4533",-0.0576,-0.161,0.484,0.568
"WP704","Methylation Pathways","WP704",0.118,0.142,0.457,0.57
"WP3872","Regulation of Apoptosis by Parathyroid Hormone-related Protein","WP3872",0.255,-0.894,0.468,0.571
"WP477","Cytoplasmic Ribosomal Proteins","WP477",-2.33,-2.18,0.545,0.571
"WP404","Nucleotide Metabolism","WP404",-0.241,-0.264,0.484,0.572
"WP4255","Non-small cell lung cancer","WP4255",-1.17,-3.26,0.876,0.577
"WP408","Oxidative Stress","WP408",0.45,-0.492,0.434,0.58
"WP4263","Pancreatic adenocarcinoma pathway","WP4263",-1.56,-3.77,0.894,0.581
"WP3931","ESC Pluripotency Pathways","WP3931",-0.827,-2.54,0.779,0.583
"WP2328","Allograft Rejection","WP2328",-0.751,-1.2,0.567,0.586
"WP1589","Folate-Alcohol and Cancer Pathway Hypotheses","WP1589",-0.0611,-0.302,0.529,0.588
"WP3655","Hypothetical Craniofacial Development Pathway","WP3655",-0.0586,-0.416,0.502,0.588
"WP3596","miR-517 relationship with ARCN1 and USP1","WP3596",-0.025,-0.425,0.469,0.589
"WP4595","Urea cycle and associated pathways","WP4595",-0.0592,-0.0348,0.48,0.595
"WP286","IL-3 Signaling Pathway","WP286",-1.08,-3.01,0.767,0.597
"WP2882","Nuclear Receptors Meta-Pathway","WP2882",0.247,-0.458,0.577,0.597
"WP481","Insulin Signaling","WP481",-1.01,-2.87,0.765,0.598
"WP4148","Splicing factor NOVA regulated synaptic proteins","WP4148",-0.138,-0.183,0.525,0.599
"WP4718","Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways)","WP4718",-0.168,-0.209,0.517,0.599
"WP3853","ERK Pathway in Huntington's Disease","WP3853",-0.81,-1.66,0.729,0.6
"WP2853","Endoderm Differentiation","WP2853",-0.134,-0.408,0.561,0.601
"WP1531","Vitamin D Metabolism","WP1531",-0.0646,-0.153,0.527,0.604
"WP3656","Interleukin-1 Induced Activation of NF-kappa-B","WP3656",-0.144,-0.676,0.523,0.606
"WP500","Glycogen Synthesis and Degradation","WP500",-0.177,-0.372,0.5,0.607
"WP134","Pentose Phosphate Metabolism","WP134",-0.343,-0.32,0.516,0.608
"WP455","GPCRs, Class A Rhodopsin-like","WP455",0.441,0.497,0.517,0.609
"WP313","Signaling of Hepatocyte Growth Factor Receptor","WP313",-0.945,-2.52,0.822,0.61
"WP4724","Omega-9 FA synthesis","WP4724",-0.054,-0.136,0.513,0.615
"WP3927","BMP Signaling Pathway in Eyelid Development","WP3927",-0.439,-1.19,0.638,0.616
"WP678","Arachidonate Epoxygenase / Epoxide Hydrolase","WP678",-0.173,-0.149,0.512,0.616
"WP4792","Purine metabolism","WP4792",-0.233,-0.191,0.52,0.617
"WP3850","Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling","WP3850",-0.323,-1.26,0.628,0.618
"WP4258","LncRNA involvement in canonical Wnt signaling and colorectal cancer","WP4258",-0.197,-0.925,0.6,0.619
"WP561","Heme Biosynthesis","WP561",-0.132,-0.0448,0.518,0.619
"WP2249","Metastatic brain tumor","WP2249",-0.509,-1.29,0.674,0.623
"WP3874","Canonical and Non-Canonical TGF-B signaling","WP3874",-0.532,-1.21,0.625,0.623
"WP1422","Sphingolipid pathway","WP1422",-0.109,-0.0785,0.552,0.626
"WP2291","Deregulation of Rab and Rab Effector Genes in Bladder Cancer","WP2291",-0.0748,0.0435,0.519,0.627
"WP3871","Valproic acid pathway","WP3871",-0.337,-0.369,0.578,0.628
"WP2359","Parkin-Ubiquitin Proteasomal System pathway","WP2359",-0.675,-0.616,0.557,0.63
"WP3634","Insulin signalling in human adipocytes (normal condition)","WP3634",-0.588,-1.22,0.687,0.63
"WP3635","Insulin signalling in human adipocytes (diabetic condition)","WP3635",-0.588,-1.22,0.687,0.63
"WP2035","Follicle Stimulating Hormone (FSH) signaling pathway","WP2035",-0.966,-2.23,0.771,0.634
"WP673","ErbB Signaling Pathway","WP673",-1.59,-3.89,0.929,0.635
"WP400","p38 MAPK Signaling Pathway","WP400",-0.913,-1.94,0.734,0.636
"WP3844","PI3K-AKT-mTOR signaling pathway and therapeutic opportunities","WP3844",-0.83,-2.26,0.768,0.638
"WP3942","PPAR signaling pathway","WP3942",-0.0627,-0.198,0.577,0.64
"WP2456","HIF1A and PPARG regulation of glycolysis","WP2456",-0.474,-0.597,0.58,0.641
"WP4239","Epithelial to mesenchymal transition in colorectal cancer","WP4239",-1.26,-2.43,0.808,0.641
"WP3644","NAD+ metabolism","WP3644",-0.11,-0.137,0.538,0.643
"WP391","Mitochondrial Gene Expression","WP391",-0.697,-0.897,0.566,0.645
"WP4483","Relationship between inflammation, COX-2 and EGFR","WP4483",-1.23,-2.35,0.838,0.645
"WP3967","miR-509-3p alteration of YAP1/ECM axis","WP3967",-0.318,-0.409,0.571,0.646
"WP2864","Apoptosis-related network due to altered Notch3 in ovarian cancer","WP2864",-0.39,-1.02,0.654,0.648
"WP2868","TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer","WP2868",-0.778,-1.78,0.701,0.65
"WP304","Kit receptor signaling pathway","WP304",-0.984,-2.9,0.802,0.65
"WP4534","Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms","WP4534",-0.642,-1.07,0.693,0.65
"WP69","T-Cell antigen Receptor (TCR)  Signaling Pathway","WP69",-1.62,-3.57,0.765,0.654
"WP4496","Signal transduction through IL1R","WP4496",-0.555,-2.31,0.677,0.659
"WP311","Synthesis and Degradation of Ketone Bodies","WP311",-0.219,-0.19,0.555,0.661
"WP2875","Constitutive Androstane Receptor Pathway","WP2875",-0.406,-0.836,0.565,0.662
"WP430","Statin Pathway","WP430",-0.133,-0.153,0.587,0.662
"WP3851","TLR4 Signaling and Tolerance","WP3851",-0.497,-1.68,0.621,0.665
"WP3651","Pathways Affected in Adenoid Cystic Carcinoma","WP3651",-1.1,-1.57,0.712,0.668
"WP2290","RalA downstream regulated genes","WP2290",-0.811,-1.37,0.724,0.679
"WP3865","Novel intracellular components of RIG-I-like receptor (RLR) pathway","WP3865",-0.964,-1.87,0.723,0.683
"WP4747","Netrin-UNC5B signaling Pathway","WP4747",-0.985,-2.22,0.799,0.683
"WP422","MAPK Cascade","WP422",-1.13,-2.47,0.816,0.684
"WP2583","T-Cell Receptor and Co-stimulatory Signaling","WP2583",-0.744,-1.81,0.637,0.685
"WP4141","PI3K/AKT/mTOR - VitD3 Signalling","WP4141",-0.575,-1.63,0.669,0.685
"WP4521","Glycosylation and related congenital defects","WP4521",-0.644,-0.502,0.574,0.685
"WP619","Type II interferon signaling (IFNG)","WP619",-0.96,-1.44,0.668,0.691
"WP49","IL-2 Signaling Pathway","WP49",-1,-3.02,0.802,0.698
"WP3937","Microglia Pathogen Phagocytosis Pathway","WP3937",-1.49,-2.05,0.73,0.702
"WP2436","Dopamine metabolism","WP2436",-0.325,-0.464,0.641,0.704
"WP2857","Mesodermal Commitment Pathway","WP2857",-0.456,-0.747,0.652,0.708
"WP3877","Simplified Depiction of MYD88 Distinct Input-Output Pathway","WP3877",-0.357,-1.09,0.629,0.712
"WP2643","Nanoparticle-mediated activation of receptor signaling","WP2643",-1.64,-3.06,0.88,0.713
"WP2637","Structural Pathway of Interleukin 1 (IL-1)","WP2637",-1.06,-2.88,0.74,0.714
"WP2916","Interactome of polycomb repressive complex 2 (PRC2) ","WP2916",-0.633,-0.627,0.603,0.716
"WP4564","Neural Crest Cell Migration during Development","WP4564",-0.828,-2.19,0.763,0.716
"WP4705","Pathways of nucleic acid metabolism and innate immune sensing","WP4705",-0.475,-0.425,0.641,0.717
"WP185","Integrin-mediated Cell Adhesion","WP185",-1.45,-2.38,0.826,0.718
"WP3969","H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity","WP3969",-0.568,-0.993,0.716,0.718
"WP4271","Vitamin B12 Disorders","WP4271",-0.497,-0.461,0.602,0.718
"WP4297","Thiamine metabolic pathways","WP4297",-0.532,-0.481,0.613,0.718
"WP4210","Tryptophan catabolism leading to NAD+ production","WP4210",-0.224,-0.184,0.604,0.719
"WP3664","Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds","WP3664",-0.58,-1.02,0.689,0.72
"WP4292","Methionine metabolism leading to Sulphur Amino Acids and related disorders","WP4292",-0.505,-0.561,0.636,0.725
"WP363","Wnt Signaling Pathway (Netpath)","WP363",-1.27,-2.47,0.796,0.726
"WP205","IL-7 Signaling Pathway","WP205",-1.24,-2.91,0.819,0.727
"WP4725","Sphingolipid Metabolism (general overview)","WP4725",-0.28,-0.251,0.631,0.727
"WP195","IL-1 signaling pathway","WP195",-1.55,-3.07,0.874,0.729
"WP3","Phytochemical activity on NRF2 transcriptional activation","WP3",-0.682,-1.16,0.738,0.729
"WP78","TCA Cycle (aka Krebs or citric acid cycle)","WP78",-1.24,-1.21,0.65,0.729
"WP3925","Amino Acid metabolism","WP3925",-0.645,-0.61,0.658,0.73
"WP4523","Classical pathway of steroidogenesis, including diseases","WP4523",-0.511,-0.462,0.635,0.73
"WP22","IL-9 Signaling Pathway","WP22",-1.18,-2.56,0.787,0.732
"WP4586","Metabolism of alpha-linolenic acid","WP4586",-0.432,-0.501,0.635,0.732
"WP1584","Type II diabetes mellitus","WP1584",-0.879,-1.51,0.753,0.735
"WP268","Notch Signaling","WP268",-0.701,-0.816,0.675,0.737
"WP3593","MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma","WP3593",-0.719,-0.776,0.682,0.737
"WP3981","miRNA regulation of prostate cancer signaling pathways","WP3981",-1.62,-3.53,0.856,0.741
"WP4301","Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells","WP4301",-1.34,-1.87,0.789,0.741
"WP1559","TFs Regulate miRNAs related to cardiac hypertrophy","WP1559",-1.12,-1.9,0.796,0.743
"WP299","Nuclear Receptors in Lipid Metabolism and Toxicity","WP299",-0.795,-0.903,0.675,0.743
"WP4559","Interactions between immune cells and microRNAs in tumor microenvironment","WP4559",-0.63,-1.46,0.695,0.743
"WP1425","Bone Morphogenic Protein (BMP) Signalling and Regulation","WP1425",-0.558,-0.703,0.673,0.748
"WP4562","Canonical NF-KB pathway","WP4562",-1.01,-2.06,0.748,0.749
"WP2876","Pregnane X Receptor pathway","WP2876",-0.632,-1.07,0.675,0.75
"WP3965","Lipid Metabolism Pathway","WP3965",-0.985,-1.44,0.727,0.75
"WP4389","Bile Acids synthesis and enterohepatic circulation ","WP4389",-0.834,-1.22,0.712,0.75
"WP399","Wnt Signaling Pathway and Pluripotency","WP399",-0.763,-1.86,0.758,0.754
"WP229","Irinotecan Pathway","WP229",-0.407,-0.416,0.677,0.755
"WP2333","Trans-sulfuration pathway","WP2333",-0.6,-0.709,0.657,0.756
"WP4742","Ketogenesis and Ketolysis","WP4742",-0.602,-0.603,0.675,0.757
"WP244","Alpha 6 Beta 4 signaling pathway","WP244",-1.71,-2.98,0.869,0.758
"WP288","NLR Proteins","WP288",-1.4,-1.98,0.814,0.759
"WP1424","Globo Sphingolipid Metabolism","WP1424",-0.338,-0.223,0.658,0.761
"WP501","GPCRs, Class C Metabotropic glutamate, pheromone","WP501",-0.626,-0.568,0.692,0.764
"WP61","Notch Signaling Pathway Netpath","WP61",-0.953,-1.88,0.749,0.764
"WP3926","ApoE and miR-146 in inflammation and atherosclerosis","WP3926",-0.57,-1.15,0.667,0.765
"WP4155","Endometrial cancer","WP4155",-1.63,-3.89,0.93,0.765
"WP2873","Aryl Hydrocarbon Receptor Pathway","WP2873",-0.988,-1.62,0.789,0.771
"WP3286","Copper homeostasis","WP3286",-0.877,-1.57,0.777,0.771
"WP4549","Fragile X Syndrome ","WP4549",-1.63,-2.41,0.864,0.771
"WP3612","Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling","WP3612",-0.586,-1.6,0.662,0.777
"WP3300","Dual hijack model of Vif in HIV infection","WP3300",-0.745,-0.704,0.683,0.778
"WP4136","Fibrin Complement Receptor 3 Signaling Pathway","WP4136",-1.22,-2.37,0.804,0.779
"WP2324","AGE/RAGE pathway","WP2324",-1.53,-3.55,0.891,0.781
"WP4537","Hippo-Yap signaling pathway","WP4537",-0.513,-0.578,0.684,0.781
"WP2884","NRF2 pathway","WP2884",-0.531,-0.814,0.72,0.783
"WP4721","Eicosanoid metabolism via Lipo Oxygenases (LOX)","WP4721",-0.592,-0.595,0.696,0.786
"WP4478","LTF danger signal response pathway","WP4478",-0.44,-1.63,0.663,0.788
"WP4582","Cancer immunotherapy by CTLA4 blockade","WP4582",-1.26,-2.05,0.837,0.789
"WP75","Toll-like Receptor Signaling Pathway","WP75",-1.67,-3.9,0.897,0.789
"WP4018","Pathways in clear cell renal cell carcinoma","WP4018",-1.19,-1.7,0.796,0.796
"WP4726","Sphingolipid Metabolism (integrated pathway)","WP4726",-0.528,-0.497,0.698,0.796
"WP2533","Glycerophospholipid Biosynthetic Pathway","WP2533",-0.899,-1.08,0.757,0.798
"WP4519","Cerebral Organic Acidurias, including diseases","WP4519",-0.617,-0.571,0.716,0.799
"WP3678","Amplification and Expansion of Oncogenic Pathways as Metastatic Traits","WP3678",-0.976,-1.2,0.803,0.8
"WP2828","Bladder Cancer","WP2828",-1.3,-2.7,0.919,0.804
"WP4542","Overview of leukocyte-intrinsic Hippo pathway functions","WP4542",-0.709,-1.28,0.701,0.806
"WP4565","Neural Crest Cell Migration in Cancer","WP4565",-1.12,-2.44,0.827,0.806
"WP2018","RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway","WP2018",-1.76,-3.7,0.893,0.812
"WP3933","Kennedy pathway from Sphingolipids","WP3933",-0.72,-0.701,0.716,0.812
"WP2854","Gene regulatory network modelling somitogenesis ","WP2854",-0.634,-0.728,0.729,0.816
"WP3934","Leptin and adiponectin","WP3934",-1.12,-1.19,0.744,0.817
"WP4150","Wnt Signaling in Kidney Disease","WP4150",-1.11,-1.66,0.82,0.824
"WP3845","Canonical  and Non-canonical Notch signaling","WP3845",-1.1,-1.25,0.785,0.825
"WP4479","Supression of HMGB1 mediated inflammation by THBD","WP4479",-1.37,-2.33,0.795,0.827
"WP2272","Pathogenic Escherichia coli infection","WP2272",-1.14,-1.55,0.777,0.828
"WP4206","Hereditary leiomyomatosis and renal cell carcinoma pathway","WP4206",-1.36,-1.58,0.816,0.829
"WP2453","TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)","WP2453",-1.36,-1.37,0.746,0.833
"WP3945","TYROBP Causal Network","WP3945",-1.84,-1.87,0.777,0.833
"WP405","Eukaryotic Transcription Initiation","WP405",-1.45,-1.35,0.744,0.833
"WP2805","exRNA mechanism of action and biogenesis","WP2805",-0.878,-0.846,0.738,0.834
"WP357","Fatty Acid Biosynthesis","WP357",-0.95,-1.05,0.746,0.837
"WP3645","NAD+ biosynthetic pathways","WP3645",-0.84,-0.859,0.749,0.846
"WP47","Hedgehog Signaling Pathway Netpath","WP47",-1.02,-0.992,0.76,0.846
"WP696","Benzo(a)pyrene metabolism","WP696",-1.35,-1.34,0.776,0.846
"WP3879","4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression","WP3879",-1.89,-2.73,0.876,0.847
"WP4656","Joubert Syndrome","WP4656",-1.59,-1.67,0.774,0.85
"WP4205","MET in type 1 papillary renal cell carcinoma","WP4205",-2.39,-4.04,0.97,0.854
"WP716","Vitamin A and Carotenoid Metabolism","WP716",-0.918,-0.994,0.805,0.854
"WP4585","Cancer immunotherapy by PD-1 blockade","WP4585",-1.82,-2.42,0.808,0.855
"WP4142","Metabolism of Spingolipids in ER and Golgi apparatus","WP4142",-0.927,-0.896,0.789,0.856
"WP100","Glutathione metabolism","WP100",-1.31,-1.39,0.8,0.859
"WP2526","PDGF Pathway","WP2526",-1.99,-3.97,0.927,0.859
"WP3858","Toll-like Receptor Signaling related to MyD88","WP3858",-1.39,-2.15,0.861,0.861
"WP4655","Cytosolic DNA-sensing pathway","WP4655",-1.59,-2.35,0.819,0.861
"WP4522","Metabolic pathway of LDL, HDL and TG, including diseases","WP4522",-0.842,-0.874,0.779,0.863
"WP12","Osteoclast Signaling","WP12",-1.19,-1.41,0.817,0.864
"WP4197","The human immune response to tuberculosis","WP4197",-1.4,-1.84,0.785,0.864
"WP4241","Type 2 papillary renal cell carcinoma","WP4241",-1.25,-1.6,0.837,0.869
"WP4494","Selective expression of chemokine receptors during T-cell polarization","WP4494",-1.58,-1.83,0.804,0.869
"WP80","Nucleotide GPCRs","WP80",-0.764,-0.737,0.781,0.871
"WP4504","Cysteine and methionine catabolism","WP4504",-1.06,-1.12,0.824,0.872
"WP3982","miRNA regulation of p53 pathway in prostate cancer","WP3982",-1.13,-1.89,0.832,0.873
"WP3676","BDNF-TrkB Signaling","WP3676",-1.81,-2.85,0.951,0.874
"WP2572","Primary Focal Segmental Glomerulosclerosis FSGS","WP2572",-1.34,-1.85,0.865,0.876
"WP2942","DDX1 as a regulatory component of the Drosha microprocessor","WP2942",-1.18,-1.3,0.78,0.877
"WP615","Senescence and Autophagy in Cancer","WP615",-1.55,-2.97,0.862,0.879
"WP3614","Photodynamic therapy-induced HIF-1 survival signaling","WP3614",-1.12,-1.55,0.845,0.881
"WP4153","Degradation pathway of sphingolipids, including diseases","WP4153",-1.23,-1.17,0.813,0.881
"WP4217","Ebola Virus Pathway on Host","WP4217",-2.39,-3.15,0.899,0.881
"WP581","EPO Receptor Signaling","WP581",-2.1,-3.12,0.941,0.884
"WP438","Non-homologous end joining","WP438",-1.34,-1.33,0.799,0.888
"WP4561","Cell migration and invasion through p75NTR","WP4561",-1.32,-2.09,0.884,0.891
"WP4722","Glycerolipids and Glycerophospholipids","WP4722",-1.12,-1.09,0.817,0.893
"WP106","Alanine and aspartate metabolism","WP106",-1.07,-1.08,0.821,0.895
"WP3413","NOTCH1 regulation of human endothelial cell calcification","WP3413",-1.18,-1.25,0.855,0.898
"WP2513","Nanoparticle triggered regulated necrosis","WP2513",-1.49,-1.72,0.885,0.906
"WP453","Inflammatory Response Pathway","WP453",-1.94,-2.05,0.851,0.906
"WP691","Tamoxifen metabolism","WP691",-1.28,-1.3,0.849,0.906
"WP4723","Omega-3/Omega-6 FA synthesis","WP4723",-1.41,-1.44,0.847,0.907
"WP111","Electron Transport Chain (OXPHOS system in mitochondria)","WP111",-3.38,-3.27,0.864,0.909
"WP3859","TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition","WP3859",-1.69,-2.2,0.902,0.91
"WP1449","Regulation of toll-like receptor signaling pathway","WP1449",-2.09,-3.95,0.943,0.911
"WP4159","GABA receptor Signaling","WP4159",-1.34,-1.31,0.835,0.911
"WP2877","Vitamin D Receptor Pathway","WP2877",-1.05,-1.53,0.868,0.912
"WP368","Mitochondrial LC-Fatty Acid Beta-Oxidation","WP368",-1.56,-1.6,0.856,0.912
"WP143","Fatty Acid Beta Oxidation","WP143",-1.79,-1.81,0.884,0.919
"WP4396","Nonalcoholic fatty liver disease","WP4396",-2.89,-4.23,0.921,0.921
"WP1433","Nucleotide-binding Oligomerization Domain (NOD) pathway","WP1433",-2.32,-2.82,0.916,0.923
"WP3869","Cannabinoid receptor signaling","WP3869",-1.61,-2.34,0.916,0.924
"WP4146","Macrophage markers","WP4146",-1.96,-1.96,0.864,0.925
"WP3680","Association Between Physico-Chemical Features and Toxicity Associated Pathways","WP3680",-2.27,-3.55,0.971,0.932
"WP1471","Target Of Rapamycin (TOR) Signaling","WP1471",-2.42,-3,0.932,0.936
"WP534","Glycolysis and Gluconeogenesis","WP534",-2.04,-2.12,0.888,0.939
"WP692","Sulfation Biotransformation Reaction","WP692",-1.77,-1.77,0.897,0.939
"WP1982","Sterol Regulatory Element-Binding Proteins (SREBP) signalling","WP1982",-1.82,-2.14,0.912,0.943
"WP4313","Ferroptosis","WP4313",-1.81,-1.81,0.92,0.947
"WP4329","miRNAs involvement in the immune response in sepsis","WP4329",-1.84,-3.22,0.91,0.947
"WP325","Triacylglyceride Synthesis","WP325",-1.77,-1.75,0.9,0.949
"WP3915","Angiopoietin Like Protein 8 Regulatory Pathway","WP3915",-2.67,-4.13,0.97,0.949
"WP43","Oxidation by Cytochrome P450","WP43",-1.88,-1.83,0.924,0.952
"WP4352","Ciliary landscape","WP4352",-3.04,-2.98,0.927,0.952
"WP4674","Head and Neck Squamous Cell Carcinoma","WP4674",-2.59,-4.28,0.979,0.952
"WP4758","Nephrotic syndrome","WP4758",-2.14,-2.12,0.932,0.962
"WP2509","Nanoparticle triggered autophagic cell death","WP2509",-1.9,-2.29,0.917,0.964
"WP710","DNA Damage Response (only ATM dependent)","WP710",-2.87,-4.92,0.987,0.97
"WP702","Metapathway biotransformation Phase I and II","WP702",-2.54,-2.42,0.937,0.972
"WP697","Estrogen metabolism","WP697",-2.58,-2.61,0.96,0.977
"WP4536","Genes related to primary cilium development (based on CRISPR)","WP4536",-2.87,-2.68,0.937,0.98
"WP4324","Mitochondrial complex I assembly model OXPHOS system","WP4324",-3.86,-3.78,0.96,0.983
"WP4532","Intraflagellar transport proteins binding to dynein","WP4532",-2.93,-2.86,0.961,0.983
"WP623","Oxidative phosphorylation","WP623",-3.56,-3.52,0.953,0.984
"WP4577","Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway","WP4577",-3.37,-3.52,0.971,0.991
